BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 2653859)

  • 1. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. At pill's 30th birthday, breast cancer question is unresolved.
    Althaus FA; Kaeser L
    Fam Plann Perspect; 1990; 22(4):173-6. PubMed ID: 2226748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use and the risk of breast cancer in young women.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jun; 33(25):353-4. PubMed ID: 6427584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
    Grimes DA
    Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and breast cancer.
    Gay JW; Cardwell MS
    Mo Med; 1990 Oct; 87(10):763-7. PubMed ID: 2259330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.
    Ravnihar B; Primic Zakelj M; Kosmelj K; Stare J
    Neoplasma; 1988; 35(1):109-21. PubMed ID: 3352833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early oral contraceptive use as a prognostic factor in breast cancer.
    Olsson H; Möller TR; Ranstam J; Borg A; Fernö M
    Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of breast cancer and hormonal contraception in Costa Rica.
    Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
    J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [P-pills and risk of breast cancer. A review of studies published 1970-1990].
    Glud E; Ewertz M
    Ugeskr Laeger; 1992 Jan; 154(5):260-6. PubMed ID: 1736458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific differences in the relationship between oral contraceptive use and breast cancer.
    Wingo PA; Lee NC; Ory HW; Beral V; Peterson HB; Rhodes P
    Obstet Gynecol; 1991 Aug; 78(2):161-70. PubMed ID: 2067757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pill and cancer of the breast and cervix uteri].
    Pedersen A
    Ugeskr Laeger; 1984 Apr; 146(14):1063-6. PubMed ID: 6730039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
    Schildkraut JM; Hulka BS; Wilkinson WE
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):395-402. PubMed ID: 2381616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L
    J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the health risks and benefits of contraceptive choices.
    Kost K; Forrest JD; Harlap S
    Fam Plann Perspect; 1991; 23(2):54-61. PubMed ID: 2060612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.